John M. Dineen - Net Worth and Insider Trading
John M. Dineen Net Worth
The estimated net worth of John M. Dineen is at least $900,269 dollars as of 2024-11-10. John M. Dineen is the Director of Syneos Health Inc and owns about 17,426 shares of Syneos Health Inc (SYNH) stock worth over $748,969. John M. Dineen is also the Director of Merrimack Pharmaceuticals Inc and owns about 10,000 shares of Merrimack Pharmaceuticals Inc (MACK) stock worth over $151,300. Details can be seen in John M. Dineen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John M. Dineen has not made any transactions after 2020-07-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John M. Dineen
John M. Dineen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John M. Dineen owns 4 companies in total, including Syneos Health Inc (SYNH) , Cognizant Technology Solutions Corp (CTSH) , and Merrimack Pharmaceuticals Inc (MACK) among others .
Click here to see the complete history of John M. Dineen’s form 4 insider trades.
Insider Ownership Summary of John M. Dineen
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SYNH | Syneos Health Inc | 2020-07-06 | director |
| CTSH | Cognizant Technology Solutions Corp | 2021-06-01 | director |
| MACK | Merrimack Pharmaceuticals Inc | 2015-08-12 | director |
 | | 2023-08-24 | director |
John M. Dineen Latest Holdings Summary
John M. Dineen currently owns a total of 2 stocks. Among these stocks, John M. Dineen owns 17,426 shares of Syneos Health Inc (SYNH) as of July 6, 2020, with a value of $748,969 and a weighting of 83.19%. John M. Dineen also owns 10,000 shares of Merrimack Pharmaceuticals Inc (MACK) as of August 12, 2015, with a value of $151,300 and a weighting of 16.81%.
Latest Holdings of John M. Dineen
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SYNH | Syneos Health Inc | 2020-07-06 | 17,426 | 42.98 | 748,969 |
| MACK | Merrimack Pharmaceuticals Inc | 2015-08-12 | 10,000 | 15.13 | 151,300 |
Holding Weightings of John M. Dineen
John M. Dineen Form 4 Trading Tracker
According to the SEC Form 4 filings, John M. Dineen has made a total of 1 transactions in Syneos Health Inc (SYNH) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Syneos Health Inc is the acquisition of 8,691 shares on July 6, 2020, which cost John M. Dineen around $513,725.
According to the SEC Form 4 filings, John M. Dineen has made a total of 0 transactions in Merrimack Pharmaceuticals Inc (MACK) over the past 5 years. The most-recent trade in Merrimack Pharmaceuticals Inc is the acquisition of 10,000 shares on August 12, 2015, which cost John M. Dineen around $1 Million.
Insider Trading History of John M. Dineen
- 1
John M. Dineen Trading Performance
GuruFocus tracks the stock performance after each of John M. Dineen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John M. Dineen is -9.28%. GuruFocus also compares John M. Dineen's trading performance to market benchmark return within the same time period. The performance of stocks bought by John M. Dineen within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John M. Dineen's insider trading performs compared to the benchmark.
Performance of John M. Dineen
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.15 | | | | | |
| Relative Return to S&P 500(%) | 5.48 | | | | | |
John M. Dineen Ownership Network
Ownership Network List of John M. Dineen
Ownership Network Relation of John M. Dineen
John M. Dineen Owned Company Details
What does Syneos Health Inc do?
Who are the key executives at Syneos Health Inc?
John M. Dineen is the director of Syneos Health Inc. Other key executives at Syneos Health Inc include Chief Financial Officer Michael J. Bonello , See remarks Stanford Rudnick , and Chief Business Officer Christian Tucat .
Syneos Health Inc (SYNH) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Syneos Health Inc (SYNH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Syneos Health Inc (SYNH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Syneos Health Inc (SYNH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Syneos Health Inc Insider Transactions
John M. Dineen Mailing Address
Above is the net worth, insider trading, and ownership report for John M. Dineen. You might contact John M. Dineen via mailing address: Merrimack Pharmaceuticals, Inc., One Kendall Square, Suite B7201, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
